Follow-on roundup: bluebird bio, Reata, Catalent

bluebird bio Inc. (NASDAQ:BLUE), Reata Pharmaceuticals Inc. (NASDAQ:RETA) and Catalent Inc. (NYSE:CTLT) each priced follow-ons late Tuesday, together raising more than $1 billion.

bluebird raised $550 million through the

Read the full 280 word article

User Sign In